Siglecs as immune cell checkpoints in disease

S Duan, JC Paulson - Annual review of immunology, 2020 - annualreviews.org
Sialic acid–binding immunoglobulin-type lectins (Siglecs) are expressed on the majority of
white blood cells of the immune system and play critical roles in immune cell signaling …

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Y Wang, KCC Johnson, ME Gatti-Mays, Z Li - Journal of hematology & …, 2022 - Springer
Immune checkpoint inhibitors targeting programmed cell death protein 1, programmed death-
ligand 1, and cytotoxic T-lymphocyte-associated protein 4 provide deep and durable …

Osteoclast multinucleation: review of current literature

J Kodama, T Kaito - International journal of molecular sciences, 2020 - mdpi.com
Multinucleation is a hallmark of osteoclast maturation. The unique and dynamic
multinucleation process not only increases cell size but causes functional alterations …

Siglec-15 as an emerging target for next-generation cancer immunotherapy

J Sun, Q Lu, MF Sanmamed, J Wang - Clinical Cancer Research, 2021 - AACR
Immunomodulatory agents blocking the PD-1/PD-L1 pathway have shown a new way to
treat cancer. The explanation underlying the success of these agents may be the selective …

Sialic acid mimetics to target the sialic acid–Siglec axis

C Büll, T Heise, GJ Adema, TJ Boltje - Trends in biochemical sciences, 2016 - cell.com
Sialic acid sugars are vital regulators of the immune system through binding to
immunosuppressive sialic acid-binding immunoglobulin-like lectin (Siglec) receptors on …

Mechanisms by which sialylated milk oligosaccharides impact bone biology in a gnotobiotic mouse model of infant undernutrition

CA Cowardin, PP Ahern, VL Kung… - Proceedings of the …, 2019 - National Acad Sciences
Undernutrition in children is a pressing global health problem, manifested in part by
impaired linear growth (stunting). Current nutritional interventions have been largely …

Therapeutic targeting of siglecs using antibody-and glycan-based approaches

T Angata, CM Nycholat, MS Macauley - Trends in pharmacological …, 2015 - cell.com
The sialic acid-binding immunoglobulin-like lectins (Siglecs) are a family of
immunomodulatory receptors whose functions are regulated by their glycan ligands. Siglecs …

An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion

G Zhen, Y Dan, R Wang, C Dou, Q Guo, M Zarr, LN Liu… - Bone research, 2021 - nature.com
Osteoporosis (OP) is a common age-related disease characterized by a deterioration of
bone mass and structure that predisposes patients to fragility fractures. Pharmaceutical …

A comprehensive review of immunoreceptor regulation of osteoclasts

MB Humphrey, MC Nakamura - Clinical reviews in allergy & immunology, 2016 - Springer
Osteoclasts require coordinated co-stimulation by several signaling pathways to initiate and
regulate their cellular differentiation. Receptor activator for NF-κB ligand (RANKL or …

[HTML][HTML] Functions and therapeutic targets of Siglec-mediated infections, inflammations and cancers

CH Lin, YC Yeh, KD Yang - Journal of the Formosan Medical Association, 2021 - Elsevier
Siglecs, sialic acid (SA)-binding immunoglobulin (Ig)-like lectins, belong to a family of Ig-like
lectins. All Siglecs have at least two domains including an extracellular domain with variable …